AI assistant
Sending…
Xencor Inc — Director's Dealing 2021
Sep 8, 2021
32653_dirs_2021-09-08_ba19705b-1602-4323-8af1-2625fe804b9c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Inmune Bio, Inc. (INMB)
CIK: 0001711754
Period of Report: 2021-09-03
Reporting Person: Xencor Inc (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-03 | Common Stock | M | 108000 | $7.80 | Acquired | 1885533 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-03 | Stock Option (Right to Buy) | $7.80 | M | 108000 | Disposed | 2021-09-08 | Common Stock (108000) | Direct |
Footnotes
F1: The shares underlying this option vested in 36 equal monthly installments beginning on April 3, 2018.
More from Xencor Inc
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Feb 25
Annual Report
2026
Feb 25
Regulatory Filings
2026
Feb 25
Director's Dealing
2026
Jan 26